Side-by-side comparison of AI visibility scores, market position, and capabilities
San Jose power management semiconductors (NASDAQ: MPWR) Q3 2025 revenue $737.2M (+18.9% YoY); Enterprise Data $191.5M (+33% QoQ) powering NVIDIA/Google/AMD AI GPU clusters, competing with Texas Instruments and Analog Devices.
Monolithic Power Systems, Inc. (MPS) is a San Jose, California-based analog and mixed-signal semiconductor company — publicly traded on NASDAQ (NASDAQ: MPWR) as an S&P 500 Information Technology component — designing high-performance power management integrated circuits for computing, cloud infrastructure, storage, automotive, industrial, and consumer applications through approximately 3,800 employees worldwide. In Q3 2025, Monolithic Power Systems reported revenue of $737.2 million (+10.9% sequentially, +18.9% year-over-year), with the Enterprise Data segment (AI server power management) reaching $191.5 million (+33% from Q2 2025) driven by strong demand for power management solutions in next-generation AI platforms from NVIDIA, Google, and AMD. CEO Michael Hsing founded MPS in 1997 and has led the company's growth from a consumer LED driver manufacturer to an AI infrastructure power management leader — with MPS power ICs now embedded in NVIDIA H100, H200, and GB200 GPU clusters as the voltage regulators that convert rack power supply voltage to the precise low-voltage, high-current supply that GPU cores require during AI training inference. MPS's proprietary Intelli-Phase multiphase power architecture delivers 99%+ efficiency for high-density AI compute power delivery — a competitive differentiation that directly affects data center PUE (power usage effectiveness) at scale.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.